Literature DB >> 25033256

Preoperative neutrophil-lymphocyte ratio before platelet-lymphocyte ratio predicts clinical outcome in patients with cervical cancer treated with initial radical surgery.

Yu Zhang1, Le Wang, Yunduo Liu, Shuxiang Wang, Pan Shang, Ya Gao, Xiuwei Chen.   

Abstract

OBJECTIVE: Several inflammatory parameters are applied to predict the survival of patients with various cancers. Neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) are 2 nonspecific markers of systemic inflammation. This study aimed to evaluate the clinicopathologic and prognostic values of NLR and PLR in patients with cervical cancer undergoing primary radical hysterectomy with pelvic lymphadenectomy.
METHODS: A total of 460 cervical cancer patients were enrolled in this study. These patients were histologically confirmed with cervical cancer from February 2005 to June 2008, at the Department of Gynecology, the Third Affiliated Hospital of Harbin Medical University, China. Their clinical and histopathological markers and complete blood counts were collected and analyzed. Prognostic factors were assessed by univariate and multivariate analyses.
RESULTS: The median NLR and PLR were 2.213 and 150.9, respectively. The clinicopathologic analysis showed that NLR was highly associated with depth of stromal infiltration (P = 0.007) and lymph node metastasis (P = 0.003), and PLR was significantly related to tumor size (P = 0.020) and lymph node metastasis (P = 0.027).Univariate analysis identified high NLR as a statistically significant poor predictive factor for the progression-free survival (PFS) (P = 0.008) and overall survival (OS) (P = 0.014), and PLR exhibited no significance on PFS (P = 0.075) and OS (P = 0.110).Multivariable analysis showed that the NLR was an independent prognostic marker for PFS (hazard ratio, 1.799; 95% confidence interval, 1.069-3.028; P = 0.027), but not for OS (hazard ratio, 1.631; 95% confidence interval, 0.968-2.750; P = 0.066).
CONCLUSIONS: Preoperative NLR and PLR were found to be correlated to unfavorable histopathologic features of cervical cancer. The preoperative NLR, but not PLR, may be used as a potential and easy biomarker for survival prognosis in patients with cervical cancer receiving initial radical hysterectomy with pelvic lymphadenectomy.

Entities:  

Mesh:

Year:  2014        PMID: 25033256     DOI: 10.1097/IGC.0000000000000219

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  30 in total

1.  Pretreatment platelet-lymphocyte ratio is an independent predictor of cervical cancer recurrence following concurrent chemoradiation therapy.

Authors:  Keiichiro Nakamura; Takeshi Nishida; Tomoko Haruma; Junko Haraga; Chiaki Omichi; Chikako Ogawa; Tomoyuki Kusumoto; Noriko Seki; Hisashi Masuyama; Yuji Hiramatsu
Journal:  Mol Clin Oncol       Date:  2015-07-01

2.  Neutrophil to Lymphocyte ratio in the diagnosis of adnexal torsion.

Authors:  Önder Ercan; Bülent Köstü; Murat Bakacak; Bora Coşkun; Aytaç Tohma; Erkan Mavigök
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  The pretreatment neutrophil-to-lymphocyte ratio predicts therapeutic response to radiation therapy and concurrent chemoradiation therapy in uterine cervical cancer.

Authors:  Makito Mizunuma; Yoshihito Yokoyama; Masayuki Futagami; Masahiko Aoki; Yoshihiro Takai; Hideki Mizunuma
Journal:  Int J Clin Oncol       Date:  2015-03-04       Impact factor: 3.402

4.  Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component.

Authors:  Ziyu Zhu; Jialiang Gao; Zhixin Liu; Chunfeng Li; Yingwei Xue
Journal:  Biomed Res Int       Date:  2021-05-03       Impact factor: 3.411

5.  Prognostic Significance of Clinicopathological Factors Influencing Overall Survival and Event-Free Survival of Patients with Cervical Cancer: A Systematic Review and Meta-Analysis.

Authors:  Shengwei Kang; Junxiang Wu; Jie Li; Qing Hou; Bin Tang
Journal:  Med Sci Monit       Date:  2022-03-09

6.  Preoperative neutrophil-to-lymphocyte ratio is an independent prognostic marker in patients with laryngeal squamous cell carcinoma.

Authors:  Xiu-Ping Tu; Qian-Hui Qiu; Liang-Si Chen; Xiao-Ning Luo; Zhong-Ming Lu; Si-Yi Zhang; Shao-Hua Chen
Journal:  BMC Cancer       Date:  2015-10-20       Impact factor: 4.430

7.  Preoperative Monocyte-to-Lymphocyte Ratio in Peripheral Blood Predicts Stages, Metastasis, and Histological Grades in Patients with Ovarian Cancer.

Authors:  Jiangdong Xiang; Lina Zhou; Xing Li; Wei Bao; Taizhong Chen; Xiaowei Xi; Yinyan He; Xiaoping Wan
Journal:  Transl Oncol       Date:  2016-11-24       Impact factor: 4.243

8.  Prognostic Value of Neutrophil-Related Factors in Locally Advanced Cervical Squamous Cell Carcinoma Patients Treated with Cisplatin-Based Concurrent Chemoradiotherapy.

Authors:  Yan-Yang Wang; Zhou-Lan Bai; Jian-Li He; Yan Yang; Ren Zhao; Ping Hai; Hong Zhe
Journal:  Dis Markers       Date:  2016-03-20       Impact factor: 3.434

9.  Cervical cancer systemic inflammation score: a novel predictor of prognosis.

Authors:  Ru-Ru Zheng; Min Huang; Chu Jin; Han-Chu Wang; Jiang-Tao Yu; Lin-Chai Zeng; Fei-Yun Zheng; Feng Lin
Journal:  Oncotarget       Date:  2016-03-22

10.  Peripheral platelet/lymphocyte ratio predicts lymph node metastasis and acts as a superior prognostic factor for cervical cancer when combined with neutrophil: Lymphocyte.

Authors:  Liang Chen; Fang Zhang; Xiu-Gui Sheng; Shi-Qian Zhang; Yue-Ting Chen; Bo-Wen Liu
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.